ATE455168T1 - Methode zur reinigung von adenoviren - Google Patents

Methode zur reinigung von adenoviren

Info

Publication number
ATE455168T1
ATE455168T1 AT01991967T AT01991967T ATE455168T1 AT E455168 T1 ATE455168 T1 AT E455168T1 AT 01991967 T AT01991967 T AT 01991967T AT 01991967 T AT01991967 T AT 01991967T AT E455168 T1 ATE455168 T1 AT E455168T1
Authority
AT
Austria
Prior art keywords
adenovirus
hydroxyapatite
purifying adenoviruses
adenoviruses
purifying
Prior art date
Application number
AT01991967T
Other languages
English (en)
Inventor
Susan Cannon-Carlson
Collette Cutler
Gary Vellekamp
Marcio Voloch
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE455168T1 publication Critical patent/ATE455168T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Filtering Materials (AREA)
  • Saccharide Compounds (AREA)
AT01991967T 2000-11-29 2001-11-28 Methode zur reinigung von adenoviren ATE455168T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25382300P 2000-11-29 2000-11-29
PCT/US2001/044684 WO2002044348A2 (en) 2000-11-29 2001-11-28 Method for purifying adenoviruses

Publications (1)

Publication Number Publication Date
ATE455168T1 true ATE455168T1 (de) 2010-01-15

Family

ID=22961846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01991967T ATE455168T1 (de) 2000-11-29 2001-11-28 Methode zur reinigung von adenoviren

Country Status (7)

Country Link
US (2) US20020064860A1 (de)
EP (1) EP1337627B1 (de)
AT (1) ATE455168T1 (de)
AU (1) AU2002232443A1 (de)
DE (1) DE60141081D1 (de)
ES (1) ES2337768T3 (de)
WO (1) WO2002044348A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1427835B1 (de) 2001-08-08 2016-01-20 The Trustees of the University of Pennsylvania Verfahren zur reinigung von virusvektoren mit sialinsäure bindenden proteinen
CN1922308A (zh) 2004-02-23 2007-02-28 克鲁塞尔荷兰公司 病毒纯化方法
WO2006065827A2 (en) * 2004-12-13 2006-06-22 Canji, Inc. Cell lines for production of replication-defective adenovirus
ATE412737T1 (de) 2005-04-11 2008-11-15 Crucell Holland Bv Virusreinigung mit ultrafiltration
EP1736538A1 (de) 2005-06-21 2006-12-27 Cytos Biotechnology AG Prozess für die preparative Reinigung von Virus-ähnlichen Partikeln (VLPs)
EP1974044B1 (de) * 2005-12-12 2011-01-26 CANJI, Inc. Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
JP2010504979A (ja) * 2006-09-29 2010-02-18 カンジ，インコーポレイテッド 遺伝子治療のための方法および組成物
ES2337973B8 (es) 2008-05-16 2011-07-21 Proyecto De Biomedicina Cima, S.L. Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad.
ES2330826B1 (es) 2008-06-04 2010-07-26 Proyecto De Biomedicina Cima, S.L. Sistema para empaquetamiento de adenovirus de alta capacidad.
EA019928B1 (ru) 2008-11-03 2014-07-30 Круселл Холланд Б.В. Способ получения аденовирусных векторов
JP2011097918A (ja) * 2009-10-07 2011-05-19 Hoya Corp 精製方法およびワクチンの製造方法
MX2012004222A (es) 2009-10-15 2012-06-08 Crucell Holland Bv Metodo para purificacion de particulas de adenovirus.
WO2011045381A1 (en) 2009-10-15 2011-04-21 Crucell Holland B.V. Process for adenovirus purification from high cell density cultures
PL2536829T3 (pl) 2010-02-15 2016-09-30 Sposób wytwarzania wektorów adenowirusowych Ad26
AR102198A1 (es) 2014-10-09 2017-02-08 Regeneron Pharma Proceso para reducir partículas subvisibles en una formulación farmacéutica
AU2017312785B2 (en) 2016-08-16 2024-10-10 Regeneron Pharmaceuticals, Inc. Methods for quantitating individual antibodies from a mixture
KR102759512B1 (ko) 2016-10-25 2025-02-03 리제너론 파아마슈티컬스, 인크. 크로마토그래피 데이터 분석을 위한 방법 및 시스템
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
TWI919355B (zh) 2018-07-02 2026-03-21 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
JP6898535B1 (ja) * 2020-06-16 2021-07-07 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 アパタイトカラムを使用したウイルスの精製方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2507339B2 (ja) * 1986-08-11 1996-06-12 三井東圧化学株式会社 粗ｔＰＡの精製方法
US5496926A (en) * 1992-01-19 1996-03-05 Yeda Research And Development Co. Ltd. Process of preparing a soluble LDL receptor
JPH07173189A (ja) 1993-12-17 1995-07-11 Masashi Kosakai リガンド存在下で二段階に分けて行うヒドロキシアパタイトクロマトグラフィーの用法
JPH08188599A (ja) 1995-01-09 1996-07-23 Toagosei Co Ltd ＩｇＹ抗体の分離精製方法
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
JPH11511326A (ja) * 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびａａｖの精製
JPH09169794A (ja) 1995-12-22 1997-06-30 Mitsubishi Materials Corp 蛋白質類の分離方法
EP0968284B1 (de) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
US7732129B1 (en) * 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US6261823B1 (en) * 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
KR100918187B1 (ko) 1998-02-17 2009-09-22 쉐링 코포레이션 바이러스를 포함하는 조성물 및 바이러스 제제의 농축방법
US6689600B1 (en) * 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
JP2000262280A (ja) 1999-03-18 2000-09-26 Asahi Optical Co Ltd ウィルスまたはウィルス性抗原の精製方法およびワクチンの製造方法

Also Published As

Publication number Publication date
EP1337627A2 (de) 2003-08-27
US7393631B2 (en) 2008-07-01
US20020064860A1 (en) 2002-05-30
US20060105456A1 (en) 2006-05-18
AU2002232443A1 (en) 2002-06-11
ES2337768T3 (es) 2010-04-29
DE60141081D1 (de) 2010-03-04
EP1337627B1 (de) 2010-01-13
WO2002044348A2 (en) 2002-06-06
WO2002044348A3 (en) 2002-11-07

Similar Documents

Publication Publication Date Title
DE60141081D1 (de) Methode zur reinigung von adenoviren
DK1075488T4 (da) Proteinoprensning ved ionbytningskromatografi
DK0851937T3 (da) Fremgangsmåde til oprensning, stabilisering eller isolering af nucleinsyrer fra biologiske materialer
ATE147512T1 (de) Sequenz-spezifische dns-bindung durch p53
AU2001253808A1 (en) Filter for purifying domestic drinking water
BRPI0410856A (pt) métodos de codificar e de decodificar sinais polifÈnicos, aparelho de codificador, e, sistema de áudio
DE50113146D1 (de) Nukleinsäure-isolierung aus stuhlproben und anderen biologischen materialien, die reich an inhibitoren sind
DE69936136D1 (de) Methode und zusammensetzungen zur luciferase-detektierung in biologischen proben
ATE314391T1 (de) Methode zur reinigung von thrombopoietin
SG77684A1 (en) Water purifying apparatus capable of reliably providing purified water with an appropriate concentration of effective chlorine in various conditions
DE69940338D1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein-polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
ATE239038T1 (de) Methode zur reinigung von keratinocyten- wachstumsfaktoren
DE60100565D1 (de) Verfahren zur Reinigung von Phosphatidylserin
BR0012422A (pt) Metodo de purificação de água, bactéria adequada para o metodo e uso destes
DE68925918D1 (de) Methode zur Reinigung von Antithrombin-III und Antithrombin-III-Zusammensetzung enthaltend dieses Antithrombin-III
ATE496939T1 (de) Methode zur reinigung von keratinozyten- wachstumfaktoren
SE8601177D0 (sv) Anvendning av hydrofoba zeoliter sasom adsorptionsmaterial vid biologisk rening av avloppsvatten
GR3025944T3 (en) Purification of factor xiii.
DE69702890D1 (de) Methode zur Vorbereitung und Reinigung von 1,1,1.-Tris(4-hydroxyphenyl)ethan
EP1351974A4 (de) Gebrauch von viren zum aufspüren oder säubern von proteinen
ATE477267T1 (de) Methode zur reinigung von proteinen
BR0014692A (pt) Processo para minimizar o uso de água nova no sistema de circulação de água em uma instalação de tratamento
EP0668613A4 (de) Methode zur bestimmung der sauerstoffkonzentration in siliziumkristallen.
BR9910715A (pt) Método para a purificação da lipoproteìna ospa de borrelia
NO952105L (no) Fremgangsmåte for å fjerne sure forurensninger inneholdt i en vaporisert ström

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties